← Back to Search

Behavioral Intervention

SupportGroove App for Spinal Cord Injury

N/A
Recruiting
Led By Alexandra L Terrill, PhD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 28 weeks
Awards & highlights

Summary

This trial tests a mobile app called SupportGroove designed for people with spinal cord injuries and their romantic partners. The app provides activities to help improve their emotional and mental well-being. Participants will be evaluated periodically to measure the program's effectiveness.

Who is the study for?
This trial is for couples where one partner has a spinal cord injury that happened at least 3 months ago. Both partners must live together, be able to read English, and have access to a smartphone or computer with internet.
What is being tested?
The study is testing SupportGroove, an 8-week mobile app program designed to help couples manage the challenges of living with a spinal cord injury.
What are the potential side effects?
Since this intervention involves using an mHealth app rather than medication, traditional side effects are not expected; however, participants may experience emotional or psychological responses.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~28 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 28 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Patient Health Questionnaire-9
Revised Dyadic Adjustment Scale
Spinal Cord Injury Quality of Life (SCI-QOL) Positive Affect and Wellbeing
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: SupportGrooveExperimental Treatment1 Intervention
8-week intervention that is remotely delivered through a mobile app, consisting of daily "quests" (positive psychology-based activities) completed individually and as a couple.
Group II: Waitlist controlActive Control1 Intervention
Participants will be waitlisted for 8 weeks.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for Spinal Cord Injury (SCI) include pharmacologic therapies, physical rehabilitation, and psychosocial support. Pharmacologic treatments often target neuroreceptors and ion channels to manage pain and spasticity, while physical rehabilitation focuses on improving motor function and mobility through exercises and neuromodulation techniques. Psychosocial support, such as the SupportGroove Mobile Application, provides resources and coping strategies for patients and their partners, addressing the emotional and social challenges of living with SCI. These treatments are crucial as they collectively aim to enhance the quality of life, functional independence, and emotional well-being of SCI patients.
Multicentre, single-blind randomised controlled trial comparing MyndMove neuromodulation therapy with conventional therapy in traumatic spinal cord injury: a protocol study.

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,127 Previous Clinical Trials
1,793,029 Total Patients Enrolled
McGuire Research InstituteOTHER
9 Previous Clinical Trials
213 Total Patients Enrolled
Alexandra L Terrill, PhDPrincipal InvestigatorUniversity of Utah
2 Previous Clinical Trials
468 Total Patients Enrolled

Media Library

SupportGroove (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05527691 — N/A
Spinal Cord Injury Research Study Groups: Waitlist control, SupportGroove
Spinal Cord Injury Clinical Trial 2023: SupportGroove Highlights & Side Effects. Trial Name: NCT05527691 — N/A
SupportGroove (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05527691 — N/A
~13 spots leftby Dec 2024